跳到正文
原文
Nature 健康护理主题·· 8 天前AI 评分53

通过改善全球认知评估弥合痴呆诊断差距

Bridging the dementia diagnostic gap by addressing cognitive assessments globally

AI 导读

这篇观点文章分析了撒哈拉以南非洲、拉丁美洲和亚洲等中低收入国家在痴呆诊断方面的系统性差距。文章指出,这些地区面临认知筛查工具缺乏文化验证、规范化参考数据稀缺、神经影像基础设施不足、社会污名化严重以及多病共存等多重障碍。

正文

Background

Dementia represents one of the most consequential health challenges of the 21st century. Globally, an estimated 57 million people currently live with dementia, a figure projected to reach 153 million by 2050, with most of this growth occurring in low- and middle-income countries (LMICs)1. Rapid1 population aging, driven by improvements in infectious disease mortality, is converging with rising rates of vascular risk factors like hypertension, diabetes, dyslipidemia, and obesity to create conditions highly conducive to dementia2. These diagnostic and care gaps exist across many LMICs in Sub-Saharan Africa (SSA), Latin America, and Asia, where rapid demographic aging and rising non-communicable disease (NCD) burden are also outpacing health system readiness1,3. By 2050, the prevalence of dementia is expected to increase by 185–357% in SSA, 131–250% in Latin America, and 200–244% in Asia4. Analyses from the 10/66 Dementia Research Group suggest that up to 56% of dementia cases in Latin America may be attributable to modifiable factors, including low educational attainment, hypertension, obesity, diabetes, hearing loss, physical inactivity, and depression5.

Dementia remains substantially underdiagnosed globally. The diagnosis typically requires a comprehensive clinical evaluation (including neurological and neuropsychological measures) with neuroimaging. In specialty centers, it is increasingly supported by fluid-based biomarker analyses (cerebrospinal fluid and plasma) and, to some extent, genetic testing6. However, these diagnostic platforms are largely unavailable or not easily accessible in most LMICs7, and even when available in high-income countries, they are largely within designated health facilities. Neuroimaging units are often concentrated in urban hospitals or privately owned. Validated comprehensive cognitive assessment tools normed for regional populations are almost absent, and biomarker testing infrastructure does not exist at scale. For instance, in Asia, the urban-rural gap is further aggravated by limited specialist distribution, geographic travel distance, and weak reimbursement models. The consequence is a diagnostic gap, contributing to most people with dementia going unrecognized, undiagnosed, and unsupported6,8. In Latin America, estimates suggest that only a small proportion of dementia cases are identified in primary care settings, while up to 77% of cases may remain undiagnosed in some countries, such as Brazil9.

These challenges are not merely a clinical problem; they demonstrate systemic inequity and impact on the socioeconomic life of people living with cognitive impairment and their families. If dementia is not diagnosed early, individuals cannot access available treatments, families cannot plan care, and governments cannot allocate resources. Without accurate prevalence data, the scientific evidence required to drive policy remains weak, and the political case for investment remains challenging. This perspective examines the system-level and sociocultural forces that sustain this gap and sets out a coherent roadmap for addressing them.

Barriers to dementia diagnosis

The scarcity of culturally validated and locally adapted cognitive screening tools

A major barrier in the diagnosis of dementia in resource-constrained settings is the lack of culturally validated and locally adapted cognitive screening tools. Commonly used screening tools in Latin America, Asia, and Africa include the Mini-Mental State Examination and the Montreal Cognitive Assessment (MoCA). However, the validity of these tools in these regions is challenged by the substantial heterogeneity in education, literacy, language, and culture7,10,11.

In Latin America, regional validation studies for these screening tools were conducted in highly educated, urban, memory-clinic samples and only in a handful of countries10. Consequently, their diagnostic performance may not generalize to populations with low educational attainment or literacy, in rural communities, or among indigenous groups. Notably, the MoCA shows a strong influence of an individual’s years of education and often requires education-specific cut-offs and cultural adaptations. Low levels of education represent one of the most substantial modifiable risk factors for dementia in LMICs; yet, most existing cognitive assessment tools have not been adequately validated in low-literacy populations. Individuals with no formal education or complete illiteracy are almost entirely excluded from validation studies, leaving a substantial and vulnerable segment of the population without access to accurate cognitive screening10.

Furthermore, in Latin America, many commonly used screening tools assess only a limited number of cognitive domains (e.g., global cognitive efficiency, memory, executive function), potentially reducing sensitivity to the heterogeneous cognitive profiles observed across Alzheimer’s disease, vascular dementia, mixed dementia, and frontotemporal dementia10. Similarly, the Identification and Intervention for Dementia in Elderly Africans (IDEA) screening tool validated in Tanzania and Nigeria only evaluates four domains: orientation, memory, language, and visuo-spatial functions, while leaving several other important cognitive areas such as attention, executive function, and processing speed unevaluated1,12,13. In Asia, validation studies of cognitive screening tools have been conducted extensively in high-income countries14,15,16,17,18,19,20,21. While evidence from LMICs is limited and somewhat restricted to a few larger countries22,23,24,25,26,27,28,29,30,31.

The scarcity of established normative reference data

Few nations in SSA, Latin America, and Asia possess normative data for multi-domain cognitive assessments22,24,27,32,33. Diagnosing dementia or Mild Cognitive Impairment without normative data is challenging since objective cognitive impairment remains a key criterion in these diagnoses2. It is well established by data from high-income countries that neuropsychological test outcomes are largely influenced by culture, education, and linguistic characteristics. Therefore, using unvalidated tools risks high false-positive rates that render epidemiological estimates unreliable6, also contributing to both over- and underdiagnosis in clinical settings. This limitation directly undermines both clinical decision-making and public health planning. Despite decades of calls for normative data, progress has been slow, a reflection of inequitable research investment. The absence of locally normed assessments does not merely limit diagnosis; it renders the true scale of dementia in these regions effectively invisible.

Brain imaging infrastructure is lacking in many regions. For example, SSA has fewer than 0.1 MRI units per 100,000 people, compared to over 30 per 100,000 in high-income countries34. Even where brain imaging technology exists, costs frequently exceed a household’s monthly income. In many public settings, maintenance for MRIs is suboptimal, leaving them often non-functional. Thus, this structural biomarker evaluation with imaging remains almost entirely unavailable. Compounding this, most aging individuals in these settings reside in rural areas with poor road infrastructure and limited transport, making travel to urban diagnostic centers logistically and financially challenging for most families35. These are not incidental shortfalls; they are structural inequities reproduced by decades of underinvestment in health systems. These gaps reflect not only resource scarcity, but inequitable distribution of existing capacity.

The compounding effects of clinical misclassification and social stigma

In many African, Latin American, and Asian communities, cognitive decline is either normalized as an inevitable feature of aging or stigmatized, thus discouraging care-seeking before dementia occurs36,37,38,39. In some cases, early symptoms may not be recognized as pathological until substantial functional decline has occurred. Memory loss may simultaneously be attributed to spiritual causes, witchcraft, or ancestral displeasure, leading families to consult traditional healers rather than biomedical practitioners40. These realities are frequently framed in literature as barriers to overcome, a framing that risks being dismissive of the legitimate social functions traditional healers serve. A more productive approach is to recognize these healers as potential partners rather than obstacles, particularly when engagement is grounded in mutual respect and cultural understanding41. Stigma around neurological and mental health conditions further suppresses disclosure and help-seeking, creating a culture of silence around dementia. Addressing these dynamics requires culturally embedded, community-informed approaches rather than externally imposed models of care. These approaches must be tailored to the heterogeneity in health literacy on a country-by-country basis.

The dual burden of unmanaged infectious and non-communicable diseases

Africa faces a unique challenge in the dual epidemiological burden of both persisting high rates of infectious diseases, including HIV and other parasitic infections (malaria24,42, onchocerciasis4,43) alongside rapidly rising NCD prevalence, including hypertension, diabetes, chronic kidney disease, and stroke1. Both HIV and cerebrovascular disease contribute to dementia risk in many regions; yet, they often remain uncontrolled, and care for both is rarely integrated into standard dementia diagnostic pathways44. Despite strong evidence linking these risk factors to dementia, most individuals, especially in rural areas, are unaware of these facts, creating prevention gaps. Primary care physicians and other healthcare workers without specialist training in brain health may misattribute cognitive symptoms to other factors, such as antiretroviral medication side effects or comorbid illnesses, foreclosing the possibility of an accurate dementia diagnosis. The siloed design of health programs, which often have separate programs for HIV care, NCD management, and mental health treatments with minimal cross-referral, perpetuates diagnostic fragmentation, resulting in missed opportunities for early detection and intervention. Collaborative interventions that promote the prevention and control of these risk factors in the region are needed to curb the overall burden.

Deficits in caregiver training and preparation

In LMICs, caregivers represent an often overlooked but important link in the dementia diagnostic pathway. In many parts of SAA and Asia, older adults are commonly accompanied by their adult children or grandchildren to medical appointments and rely on them to manage their healthcare, even before cognitive impairment occurs. These “caregivers” are uniquely positioned to recognize subtle changes during the earliest stages of cognitive impairment. However, the paucity of health literacy and inaccessible referral pathways means that early symptoms are routinely normalized or misattributed to aging. This often results in delayed recognition and prolongs the diagnostic journey.

The caregiving burden falls disproportionately on women, who provide most of the informal dementia care, often at the cost of their own education, economic participation, and long-term wellbeing45,46. This caregiving dynamic not only deepens existing social inequities by sex but also undermines care-seeking behavior, as caregivers who are economically marginalized and socially overburdened are less able to navigate health systems to obtain a diagnosis for the person they support47,48. Compounding these further, informal caregivers from LMICs often share similar environmental exposures and vascular risk profiles as those they care for. Coupled with the stress from caregiving that causes abnormal cortisol levels and proinflammatory states, as well as promoting self-neglect and burnout, place them at increased risk of cognitive impairment6,7,49,50. Strengthening community-based support systems that recognize, train, and resource informal caregivers is a strategic prerequisite for improving early symptom recognition and facilitating timely diagnosis in resource-constrained settings.

The lack of a unified national policy framework

National dementia strategies are infrequent in LMICs. For example, fewer than a quarter of countries in SSA have any form of national dementia policy or plan51,52,53. Without policy frameworks, dementia lacks the institutional visibility to attract funding, workforce development, or health system reform. International research funders have historically prioritized infectious diseases over chronic NCDs, including dementia, producing a thin evidence base that, in turn, weakens domestic policy arguments, a cycle that can only be interrupted by deliberate, targeted investment. Meanwhile, the millions of people currently living with undiagnosed dementia remain politically invisible54. In Asia, the more rapid demographic aging shifted the focus of domestic policies to NCDs and dementia, although the effect of these shifts remains to be seen39.

A pathway forward

The articles in this series, Cognitive Assessment Across Global Aging Populations, highlight work aimed at reducing barriers around cognitive assessments in regions where few validated tools exist. Articles address themes such as the cultural adaptation of screening tools, the development of normative data in low-resource settings, task-shifting approaches to cognitive screening, and the integration of digital tools into community-based assessment programs.

Consortia such as the Human Heredity and Health in Africa, the Harmonized Cognitive Assessment Protocol, and the Building Research Infrastructure in Dementia for Global Equity multi-domain cognitive assessment protocol represent steps forward to addressing common barriers to dementia diagnosis, but there is still more to be done55,56. Comprehensive cognitive assessments must be grounded in the demands of daily life experienced by urban and rural adults in these regions, including oral memory, occupational performance, and spatial reasoning. Investment in this foundational work will yield compounding returns across research, clinical practice, and policy.

Routine dementia screening can be practically and effectively embedded into existing care programs for chronic diseases such as diabetes and hypertension. This approach is a straightforward avenue to scale up even in settings with limited resources, making it a highly impactful strategy for early detection of cognitive decline. Older individuals already attending non-communicable and communicable disease clinics are a high-risk population, and validated short screening tools administered by trained primary care workers can identify those requiring specialist referral without building parallel infrastructure8. Task-shifting to community health workers (CHWs) can extend the reach of screening further, provided it is accompanied by adequate training, supervision, and remuneration- conditions that pilot programs have not always fulfilled. Health system strengthening must accompany any screening expansion; adding tasks to overburdened workers without additional resources risks superficial implementation and poor data quality. Integration, rather than parallel system creation, is likely to yield more sustainable outcomes. Interventions targeting physical activity, dietary patterns, sleep quality, social engagement, and cardiovascular risk factor management demonstrate meaningful cognitive benefits in recent multi-domain prevention trials57.

Integration of digital tools into community-based cognitive assessment programs

Tablet and smartphone-based cognitive assessment tools using non-verbal, oral, or story-based paradigms can reduce literacy bias and extend screening to remote populations58. Mobile health platforms enable CHWs to collect data and flag individuals for follow-up, dramatically widening specialist reach. However, enthusiasm for digital solutions must be tempered with reality. Digital cognitive assessments represent a promising opportunity to expand access, reduce examiner-related variability, and improve scalability; however, their implementation requires rigorous validation across the linguistic, educational, cultural, socioeconomic, and technological diversity that characterize LMICs59,60. The implementation of digital cognitive assessment and dementia awareness tools in LMICs faces multidimensional feasibility barriers that extend well beyond age-related differences in technology familiarity. Smartphone ownership, reliable internet connectivity, electricity access, data costs, and technological literacy vary substantially across urban and rural populations and cannot be assumed even among younger adults in many LMICs settings61. These intersecting barriers risk reinforcing existing health inequities if they are not explicitly identified and addressed from the outset of implementation planning.

Implementation science frameworks, such as the Consolidated Framework for Implementation Research, offer structured approaches for embedding equity and scalability considerations into digital health deployment strategies before they reach communities62. The digital divide in LMICs is not merely a question of individual user capability; it reflects broader structural deficits in connectivity infrastructure, regulatory oversight, and data governance that require system-level responses. Issues of data privacy, community ownership of health data, and algorithmic accountability must therefore be carefully considered, particularly in contexts where legal and regulatory frameworks for digital health remain underdeveloped. Text-based and offline-compatible digital tools may offer more equitable and contextually appropriate pathways for dementia risk communication and cognitive screening in these settings, given their lower infrastructure demands. Across all implementation strategies, digital tools must be designed to complement and strengthen existing health system capacities rather than substitute for them.

The role of nonbiomedical practitioners

Structured partnerships between biomedical practitioners and traditional healers have demonstrated feasibility in HIV and mental health contexts in SSA and offer a promising model for dementia63. Traditional healers trained to recognize early warning signs and refer appropriately could reduce diagnostic delays. Additionally, broader engagement with religious leaders, women’s groups, and village elders could shift health-seeking norms within communities. Public dementia awareness campaigns embedded in trusted community structures are likely more effective than clinic-based messaging alone, provided they are co-developed with communities rather than imposed externally44.

Development and implementation of national dementia policies

The development of national dementia policies is both a public health and political imperative. The World Health Organization Global Action Plan on Dementia 2017–2025 and Alzheimer’s Disease International frameworks provide adaptable templates64,65. Yet, domestic political champions and civil society advocacy are prerequisites that cannot be externally mandated. Governments in these regions must commit to financing alongside planning. International development partners can simultaneously redirect a meaningful share of global health research funding toward NCDs, such as dementia.

Conclusion

Globally, LMICs in SSA, Latin America, and Asia face a challenge of growing proportions against which their current health systems are structurally unprepared. Barriers to dementia diagnosis, including inadequate tools, absent infrastructure, sociocultural complexity, multimorbidity, and policy neglect, are intersecting and deeply rooted, but not insurmountable. The solutions outlined here offer a feasible roadmap, contingent on the urgency, resources, and political will required by the scale of the challenge.

The global research and policy community’s historical approach that has tended to support data extraction without meaningful knowledge transfer and chronic underfunding of international investigator-led research remain barriers. The formation of diagnostic frameworks based on cognitive norms that have been developed in high-income countries rather than the regional realities found in LMICs also contributes to the current situation. Genuine progress requires not only technical innovation but also fundamental reorientation of global health research toward equity and local ownership. Each year without purposeful action corresponds to millions of people developing avoidable and unrecognized health challenges. These conditions must be responded to with urgency.

Data availability

No datasets were generated or analyzed during the current study.

References

  1. Feigin, V. L. et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 459–480 (2019).

    Article  Google Scholar 

  2. Rossetti, H. C., Lacritz, L. H., Cullum, C. M. & Weiner, M. F. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 77, 1272–1275 (2011).

    Article  PubMed  Google Scholar 

  3. Arvanitakis, Z., Shah, R. C. & Bennett, D. A. Diagnosis and management of dementia: review. JAMA 322, 1589 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Nichols, E. et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105–e125 (2022).

    Article  Google Scholar 

  5. Mukadam, N., Sommerlad, A., Huntley, J. & Livingston, G. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob. Health 7, e596–e603 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gray, W. K. et al. Population normative data for three cognitive screening tools for older adults in Sub-Saharan Africa. Dement. Neuropsychol. 15, 339–349 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Parra, M. A. et al. Dementia in Latin America. Neurology 90, 222–231 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Musyimi, C. W., Mutiso, V. N., Nandoya, E. S. & Ndetei, D. M. Forming a joint dialogue among faith healers, traditional healers and formal health workers in mental health in a Kenyan setting: towards common grounds. J. Ethnobiol. Ethnomed. 12, 4 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Nakamura, A. E., Opaleye, D., Tani, G. & Ferri, C. P. Dementia underdiagnosis in Brazil. The Lancet 385, 418–419 (2015).

    Article  Google Scholar 

  10. Custodio, N. et al. Systematic review of the diagnostic validity of brief cognitive screenings for early dementia detection in Spanish-speaking adults in Latin America. Front. Aging Neurosci. 12, 270 (2020).

  11. Ibanez, A. et al. The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): driving multicentric research and implementation science. Front. Neurol. 12, 631722 (2021).

  12. Gray, W. K. et al. Development and validation of the Identification and Intervention for Dementia in Elderly Africans (IDEA) study dementia screening instrument. J. Geriatr. Psychiatry Neurol. 27, 110–118 (2014).

    Article  PubMed  Google Scholar 

  13. Paddick, S.-M. et al. Validation of the Identification and Intervention for Dementia in Elderly Africans (IDEA) cognitive screen in Nigeria and Tanzania. BMC Geriatr. 15, 53 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ataka, T. & Kimura, N. Application of the Cogstate Brief Battery in assessing cognitive function in older Japanese individuals. J. Alzheimer’s Dis. 107, 146–153 (2025).

    Article  Google Scholar 

  15. Baek, M. J., Park, Y. H. & Kim, S. Comparison between the Mini-Mental State Examination and the Mini-Mental State Examination-2 in patients with mild cognitive impairment and Alzheimer’s disease. J. Korean Med. Sci. 40, e235 (2025).

  16. Dikmeer, A. et al. A concise instrument for screening cognitive impairment: validation in a geriatric population. Aging Clin. Exp. Res. 37, 196 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fujiwara, Y. et al. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr. Gerontol. Int. 10, 225–232 (2010).

    Article  PubMed  Google Scholar 

  18. Kuan, Y.-C. et al. Cogstate Brief Battery performance in assessing cognitive impairment in Taiwan: a prospective, multi-center study. J. Formos. Med. Assoc. 125, 191–199 (2026).

    Article  PubMed  Google Scholar 

  19. Lee, J.-Y. et al. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean Version of the Montreal Cognitive Assessment. J. Geriatr. Psychiatry Neurol. 21, 104–110 (2008).

    Article  PubMed  Google Scholar 

  20. Lim, J. P. et al. Optimising dementia screening in community-dwelling older adults: a rapid review of brief diagnostic tools in Singapore. Ann. Acad. Med. Singap. 53, 742–753 (2024).

    Article  PubMed  Google Scholar 

  21. Sun, W. et al. A validation study of the Hong Kong Brief Cognitive Test for screening patients with mild cognitive impairment and Alzheimer’s disease. J. Alzheimer’s Dis. 88, 1523–1532 (2022).

    Article  Google Scholar 

  22. Fitri, F. I. et al. Modified Brief Cognitive Screening Battery—Indonesian Version: cross-cultural adaptation and normative data based on demographic factors in North Sumatra, Indonesia. Front. Neurol. 14, 1306356 (2024).

  23. Koc Okudur, S., Dokuzlar, O., Usarel, C., Soysal, P. & Isik, A. T. Validity and reliability of rapid cognitive screening test for Turkish older adults. J. Nutr. Health Aging 23, 68–72 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Hemrungrojn, S. et al. Use of the Montreal Cognitive Assessment Thai Version to discriminate amnestic mild cognitive impairment from Alzheimer’s disease and healthy controls: machine learning results. Dement. Geriatr. Cogn. Disord. 50, 183–194 (2021).

    Article  PubMed  Google Scholar 

  25. Gowda, R. J., Mehta, A. & Jayanna, K. Development of a cognitive screening tool for adults to detect early dementia at primary care level: a pilot study in Southern India. Neurol. India 74, 241–248 (2026).

    Article  PubMed  Google Scholar 

  26. Fu, X. et al. Chinese Version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer’s disease. J. Prev. Alzheimer’s Dis. 8, 175–180 (2021).

    Article  CAS  Google Scholar 

  27. McCauley, S. R. et al. Developing a culturally competent neuropsychological assessment battery for Vietnamese-speaking patients with suspected dementia. Archives of Clinical Neuropsychology 38, 485–500 (2023).

    Article  PubMed  Google Scholar 

  28. Panchawagh, S. & Kadam, D. A brief literacy-independent screening tool to detect cognitive impairment. Clin. Neurol. Neurosurg. 249, 108776 (2025).

    Article  PubMed  Google Scholar 

  29. Parlak, M. M., Bizpınar Munis, Ö., Köse, A., Yıldırım, C. & Ülker, C. A. The Turkish validity and reliability of Addenbrooke’s Cognitive Examination III. Int. J. Lang. Commun. Disord. 60, e13147 (2025).

  30. Yu, J., Li, J. & Huang, X. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study. BMC Psychiatry 12, 156 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  31. kojaie-Bidgoli, A. et al. Applicability of SPMSQ in illiterate outpatients in clinics: the validity and reliability of the Short Portable Mental Status Questionnaire. Appl. Neuropsychol. Adult 29, 591–597 (2022).

    Article  PubMed  Google Scholar 

  32. HSIEH, S. & TORI, C. Normative data on cross-cultural neuropsychological tests obtained from Mandarin-speaking adults across the life span. Arch. Clin. Neuropsychol. 22, 283–296 (2007).

    Article  PubMed  Google Scholar 

  33. Ryan, J. J., Yamaguchi, T. & Kreiner, D. S. Preliminary validation of the Rey 15-Item Test and Reliable Digit Span in native Japanese samples. Psychol. Rep. 122, 1925–1945 (2019).

    Article  PubMed  Google Scholar 

  34. Ogbole, G. I., Adeyomoye, A. O., Badu-Peprah, A., Mensah, Y. & Nzeh, D. A. Survey of magnetic resonance imaging availability in West Africa. Pan Afr. Med. J. 30, 240 (2018).

  35. Beran, D. et al. Research capacity building—obligations for global health partners. Lancet Glob. Health 5, e567–e568 (2017).

    Article  PubMed  Google Scholar 

  36. Paddick, S.-M. et al. Dementia prevalence estimates in Sub-Saharan Africa: comparison of two diagnostic criteria. Glob. Health Action 6, 19646 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  37. Farina, N. et al. Awareness, attitudes, and beliefs of dementia in Indonesia. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 16, e12570 (2024).

  38. Srikajornlarp, S., Lerksuthirat, T., Patpong, P., Ongphiphadhanakul, B. & Chattaris, T. Exploring public perceptions of dementia on Twitter (X): a cross-cultural analysis. Alzheimer’s Dement. 21, e70042 (2025).

  39. Iwatsubo, T. et al. Modernizing diagnosis of Alzheimer’s disease: a review of global trends and Asia-specific perspectives. Alzheimer’s Dement. 21, e70536 (2025).

  40. Brooke, J. & Ojo, O. Contemporary views on dementia as witchcraft in sub-Saharan Africa: A systematic literature review. J. Clin. Nurs. 29, 20–30 (2020).

    Article  PubMed  Google Scholar 

  41. McGlinchey, E. et al. Bridging perspectives: the value of collaboration between Traditional Healing Practitioners and Medical Doctors in dementia research and care in South Africa. Alzheimer’s Dement. 21, e70370 (2025).

  42. Ngarka, L., Agbor, C. A., Mah, E., Njamnshi, L. N. & Njamnshi, A. K. ‘The Silent Struggle: Neurocognitive Impairment and Epilepsy in Children After Severe Malaria in Endemic Regions’. Alzheimer’s Dement. 21, e104645 (2025).

  43. Njamnshi, W. Y. et al. Dementia Prevalence and Onchocerca volvulus Infection among Rural Elderly Persons in the Ntui Health District, Cameroon: a population-based study. Pathogens 13, 568 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  44. Alemayehu, Z. G. et al. Dementia in Sub-Saharan Africa: risk factors, public perception, and management approaches. J. Med. Surg. Public Health 7, 100204 (2025).

    Article  Google Scholar 

  45. Foong, H. F., Ibrahim, R., Abdullah, S. F. Z. & Bagat, M. F. Longitudinal relationship between loneliness and cognitive function among unmarried older adults in Malaysia: exploring gender disparities. Psychogeriatrics 24, 1313–1323 (2024).

    Article  PubMed  Google Scholar 

  46. Kalaria, R. et al. The 2022 symposium on dementia and brain aging in low- and middle-income countries: highlights on research, diagnosis, care, and impact. Alzheimer’s Dement. 20, 4290–4314 (2024).

    Article  Google Scholar 

  47. Fink, I. A. et al. The burden of informal caregivers of people with dementia: an integrative review. Alzheimer’s Dement. 21, e107599 (2025).

  48. Seeher, K., Cataldi, R., Dua, T. & Kestel, D. Inequitable access to dementia diagnosis and care in low-resource settings—a global perspective. Clin. Gerontol. 46, 133–137 (2023).

    Article  PubMed  Google Scholar 

  49. Macias-Aguinaga, V. & Mateu-Mollá, J. Is caregiving for someone with neurocognitive disorder a risk factor for developing cognitive decline? A systematic review of cognitive function among informal caregivers. Alzheimer’s Dement. 21, e106172 (2025).

  50. Alves, L. C. et al. Burnout syndrome in informal caregivers of older adults with dementia: a systematic review. Dement. Neuropsychol. 13, 415–421 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  51. Ayele, B. A. et al. The need for a tailored national dementia plan in Ethiopia: a call for action. Front. Neurol. 14, 1126531 (2023).

  52. Prince, M. et al. World Alzheimer Report 2015. The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends. (Alzheimer’s Disease International, 2015).

  53. World Health Organisation. Global Action Plan on the Public Health Response to Dementia 2017-2025. 52 (World Health Organization, 2017).

  54. George-Carey, R. et al. An estimate of the prevalence of dementia in Africa: a systematic analysis. J. Glob. Health 2, 020401 (2012).

  55. Riang’a, R. M. et al. Contextualization of Harmonized Cognitive Assessment Protocol (HCAP) in an aging population in rural low-resource settings in Africa: Experiences and strategies adopted to optimize effective adaption of cognitive tests in Kenya. Alzheimer’s Dement. 21, e70552 (2025).

  56. GBHI.org. Institute GBH. Building capacity and assessing risk for dementia in diverse populations. https://reporter.nih.gov/project-details/.

  57. Rosenberg, A., Mangialasche, F., Ngandu, T., Solomon, A. & Kivipelto, M. Multidomain interventions to prevent cognitive impairment, Alzheimer’s disease, and dementia: from FINGER to World-Wide FINGERS. J. Prev. Alzheimer’s Dis. 7, 29–36 (2020).

    Article  CAS  Google Scholar 

  58. Aretouli, E. & Brandt, J. Everyday functioning in mild cognitive impairment and its relationship with executive cognition. Int. J. Geriatr. Psychiatry 25, 224–233 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  59. Giaquinto, F., Battista, P. & Angelelli, P. Touchscreen cognitive tools for mild cognitive impairment and dementia used in primary care across diverse cultural and literacy populations: a systematic review. J. Alzheimer’s Dis. 90, 1359–1380 (2022).

    Article  Google Scholar 

  60. Thompson, L. I. et al. Acceptable standards for clinic-based digital cognitive assessments: recommendations from the Global CEO Initiative on Alzheimer’s disease. Alzheimer’s Dement. 21, e70966 (2025).

  61. Awosiku, O. V. et al. Role of digital health technologies in improving health financing and universal health coverage in Sub-Saharan Africa: a comprehensive narrative review. Front. Digit. Health 7, 1391500 (2025).

  62. Damschroder, L. J., Reardon, C. M., Widerquist, M. A. O. & Lowery, J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement. Sci. 17, 75 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  63. Solera-Deuchar, L., Mussa, M. I., Ali, S. A., Haji, H. J. & McGovern, P. Establishing views of traditional healers and biomedical practitioners on collaboration in mental health care in Zanzibar: a qualitative pilot study. Int. J. Ment. Health Syst. 14, 1 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  64. Barbarino, P., Aguilar, D., Arthurton, L. & Lynch, C. From Plan To Impact—expediting progress towards targets of the WHO Global Action Plan on Dementia. Alzheimer’s Dement. 20, e088171 (2025).

  65. Cahill, S. WHO’s global action plan on the public health response to dementia: some challenges and opportunities. Aging Ment. Health 24, 197–199 (2020).

    Article  PubMed  Google Scholar 

Download references

Funding

No funding was received for this work.

Author information

Author notes

  1. These authors contributed equally: David Larbi Simpong, Constance Ayuk Agbor Epse Ebot.

Authors and Affiliations

  1. School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana

    David Larbi Simpong

  2. Global Brain Health Institute, University of California, San Francisco, CA, USA

    David Larbi Simpong, Constance Ayuk Agbor Epse Ebot, Matenyeh Kaba, Sarah McDonagh, Poosanu Thanapornsangsuth & Victor Valcour

  3. Brain Research Africa Initiative, Yaoundé, Cameroon

    Constance Ayuk Agbor Epse Ebot

  4. Edward and Pearl Fein Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA

    Matenyeh Kaba, Sarah McDonagh & Victor Valcour

  5. Department of Life and Behavioral Sciences, Cognitive Neuroscience Center, Universidad de San Andrés, Buenos Aires, Argentina

    Sol Fittipaldi

  6. Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland

    Sol Fittipaldi

  7. Thai Red Cross Emerging Infectious Diseases Health Science Centre, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand

    Poosanu Thanapornsangsuth

  8. Department of Cognitive Neurology, Fleni, Buenos Aires, Argentina

    Lucia Crivelli

Authors

  1. David Larbi Simpong
  2. Constance Ayuk Agbor Epse Ebot
  3. Matenyeh Kaba
  4. Sarah McDonagh
  5. Sol Fittipaldi
  6. Poosanu Thanapornsangsuth
  7. Victor Valcour
  8. Lucia Crivelli

Contributions

V.V., D.L.S. and C.A.A.E.E.: conceptualization, drafting, and writing and editing. M.K., S.M., L.C., S.F. and P.T.: writing and editing.

Corresponding author

Correspondence to Victor Valcour.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simpong, D.L., Agbor Epse Ebot, C.A., Kaba, M. et al. Bridging the dementia diagnostic gap by addressing cognitive assessments globally. npj Dement. 2, 102 (2026). https://doi.org/10.1038/s44400-026-00144-1

Download citation

  • Received: 20 April 2026

  • Accepted: 02 September 2026

  • Published: 12 November 2026

  • Version of record: 12 November 2026

  • DOI: https://doi.org/10.1038/s44400-026-00144-1

来源:Nature 健康护理主题 · nature.com